期刊文献+

62例乳腺癌保乳手术与改良根治术的临床疗效对比 被引量:4

62 Cases of Breast Cancer, Breast Surgery and the Clinical Effect of Modified Radical Mastectomy Contrast
下载PDF
导出
摘要 目的探析保乳手术和改良根治手术治疗早期乳腺癌的临床效果。方法综合分析62例我院诊治的早期乳腺癌患者的临床资料,随机分为实验组和对照组,实验组给予保乳手术进行治疗,对照组给予改良根治手术进行治疗,比较两组的手术时间、手术出血量、生存率及美容效果满意率等。结果实验组的平均引流量、术中出血量及并发症发生率均低于对照组,实验组的手术时间和住院时间均比对照组少,实验组美容效果的满意率高于对照组,各项组间差异均具有统计学意义(P<0.05)。两组的生存率与复发率比较,差异不显著(P>0.05)。结论保乳手术治疗早期乳腺癌是一种安全、有效的手术方法。 Objective Analysis the breast surgery and modified radical surgery for early breast cancer clinical effect. Methods 62 cases of our comprehensive analysis of diagnosis and treatment of early breast cancer patient's clinical material, randomly divided into the experimental group and the control group, the experimental group was given the breast surgery in the treatment group, give improved radical surgery treatment, compared with two groups of operation time, operation amount of bleeding, survival and hairdressing effect satisfaction rate, etc. Results The average lead flow, during the operation, the amount of bleeding and complication rates arc lower than those of the control group, the experimental operation time and hospital stay were less than the control group, the experimental group beauty effect of satisfaction rate higher than that of the control group, the difference between groups were significant (P〈0.05). Two groups of survival and the recurrence rate comparison, no significant difference (P〉0.05). Conclusion The breast surgery for early breast cancer treatment is a safe and effective surgical method.
作者 郭方东
出处 《中国医药指南》 2013年第17期40-41,共2页 Guide of China Medicine
关键词 乳腺癌 保乳手术 改良根治术 Breast cancer The breast surgery Modified radical mastectomy
  • 相关文献

参考文献3

二级参考文献22

  • 1张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:247
  • 2张保宁,宣立学,王仲照.乳腺癌综合治疗的现状与展望[J].中国实用外科杂志,2006,26(4):243-245. 被引量:46
  • 3秦贤举,陈君雪,张宏伟,赵大方,张华,罗文杰,黄倩,练士贤,童汉兴.216例女性乳腺癌保乳手术及综合治疗的临床分析[J].临床肿瘤学杂志,2006,11(7):521-524. 被引量:15
  • 4常兴华,王志军.乳腺癌保乳术术后局部复发的相关因素[J].现代肿瘤医学,2007,15(3):433-436. 被引量:13
  • 5Heller W, Mazhar D, Ward R, et al. Neoadjuvant 5-fluorouraeil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer [J]. OncolRep, 2007, 17(1): 253-259.
  • 6Gonzalez-Angulo AM, blorales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer[ J]. Adv Exp Med Biol, 2007, 608:1 -22.
  • 7van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial[ J]. Natl Cancer Inst, 2000, 92 (14) : 1143 - 1150.
  • 8Kokubo M, Mitsumori M, Ishikura S, et al. Results of breast-conserving therapy for early stage breast cancer: kyoto university experiences[J]. Am J Clln Oneol, 2000, 23(5) : 499 -505.
  • 9Foulkes WD, Chappuis PO, Wong N, et al. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome [ J]. Ann Oncol, 2000, 11(3) : 307 -313.
  • 10Thomas JS, Julian HS, Green RV, et al. Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring [J].Histopathology, 2007, 51(2) : 219 -226.

共引文献102

同被引文献50

  • 1张保宁.乳腺癌保乳手术的研究进展[J].中国普外基础与临床杂志,2005,12(3):204-206. 被引量:103
  • 2来红霞,来洪磊.早期乳腺癌保留乳房手术64例疗效评价[J].实用诊断与治疗杂志,2007,21(10):791-792. 被引量:4
  • 3Chang AP, Sacchini V. Nipple-sparing mastectomy :where are we now?[J]. Surg Oncol, 2008,17 (4) : 261-266.
  • 4Fisher B, Anderson S,Bryant J, et al. Twenty-year follow-up of a randomized trim comparing total mastectomy, lumpeetomy, and lumpectomy plus irra- diation for the treatment of invasive breast cancer[J]. N Engl J Med ,2002, 347(16) : 1233-1241.
  • 5NIH consensus conference. Treatment of early-stage breast cancer[J]. JAMA, 1991,265( 1 ) :391-395.
  • 6Rouzier R ,Mathieu MC ,Sideris L,et al. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors[J]. Cancer,2004,101 (5) :918-925.
  • 7Bear HD ,Anderson S,Smith RE ,et al. Sequential preoperative or post- operative docetaxel added to preoperative doxorubicin plus cyclophospha- mide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol, 2006,24 ( 13 ) : 2019-2027.
  • 8Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a pro- spective policy of margin-directed radiation dose escalation in breast-con- serving therapy[J]. Cancer, 2003,97 ( 1 ) : 30-39.
  • 9Struikmans H,Aarts MJ,Jobsen JJ,et al. An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast caneer from 1997 till 2008 :a population-based study in the Netherlands[J]. Ra- diother Oncol, 2011,100 (2) : 320-325.
  • 10Park SS, Grills IS, Chen PY, et al. Accelerated partial breast irradiation for pure ductal carcinoma in situ[J]. Int J Radiat Oncol Biol Phys ,2011, 81 (2) :403-408.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部